Login
$FDMT
$11.29 -$0.94 (7.69%) Live

Company Executives

Officer Age In this role 2025 pay Source
Kristian Humer
Chief Financial Officer and Principal Accounting Officer
51 Not stated $3,990,903
Christopher Simms
Chief Commercial and Business Officer
51 Since 2025
1 year
Not reported
Scott Bizily
Chief Legal Officer and Corporate Secretary and Chief Compliance Officer
54 Not stated Not reported
David Kirn Also a director
See Remarks
Title from the Form 4 dated Oct 5, 2026
64 Not stated $2,051,343

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Directors
8
serving now
Independent
3 of 4
stated in the proxy; 4 not stated
Average tenure
6.9 years
from year joined
CEO also chairs the board
No
John F. Milligan, Ph.D.
Director Age On board Independent Committees Other public boards 2025 pay Source
John F. Milligan, Ph.D.
65 2020
6 years
Not stated None stated Pacific Biosciences of California $255,000
David Kirn, M.D.
64 2013
13 years
Not independent None stated None stated Paid as CEO
Glenn Sblendorio
70 2026
this year
Not stated
Compensation Committee
Mineralys Therapeutics, Inc., Amicus Therapeutics, Inc. Not stated
Jacob Chacko, M.D., MBA
47 2019
7 years
Independent None stated None stated $135,000
Susannah Gray, MBA
65 2020
6 years
Independent None stated AnaptysBio, Inc. $135,000
Charles Theuer, M.D., Ph.D.
62 2015
11 years
Independent None stated None stated $135,000
Nancy Miller-Rich
67 2020
6 years
Not stated
Compensation Committee
Aldeyra Therapeutics, Inc. $122,500
Shawn Cline Tomasello, MBA
67 2020
6 years
Not stated None stated Cabaletta Bio, Inc. $132,500

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

No related-party transactions disclosed

The proxy filed Apr 28, 2026 describes a review policy but reports no transactions.

Read the policy in the proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support